Understanding post-transcriptional mechanisms that support mitochondrial homeostasis and neuronal function
Active Grant Awarded
- Award ID
- RNS152185UAJWR1
- Recipient
-
The Ohio State University UEI DLWBSLWAJWR1
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $627,318
Award facts
- Assistance listing
- 93.NS1 Neurosciences and Neurological Disorders – Research Projects (RP)
- Completion date 0% complete
- Place of performance
- Columbus, OH 43210, USA
Award details come from USAspending.gov.
About this award
The National Institute of Neurological Disorders and Stroke, within the National Institutes of Health and the Department of Health and Human Services, awarded Grant RNS152185UAJWR1 to The Ohio State University, acting through its Office of Sponsored Programs, with $627,318 obligated on November 17, 2026. The award falls under the Neurosciences and Neurological Disorders – Research Projects (RP) program, CFDA 93.NS1. The funded research examines post-transcriptional mechanisms that support mitochondrial homeostasis and neuronal function. Its stated questions cover how nuclear-encoded mitochondrial mRNAs are localized and translated at the mitochondrial surface, what regulates the synthesis of the factors involved, and how disruption of these processes alters mitochondrial number and function. The project also addresses how mutations in the PUMILIO1 (PUM1) gene contribute to spinocerebellar ataxia type 47, a condition marked by early-onset neurodevelopmental disorder and ataxia. Work is performed in Columbus, Ohio, with a period of performance ending November 30, 2031.
Description
Project summary mitochondria are specialized organelles that generate fuel and metabolites for cell growth and homeostasis. Mitochondrial activity is essential for human health. Alterations in mitochondrial function result in a number of severe human pathologies including neuronal degeneration and ataxia. Mitochondria represent a unique cellular structure that enables specialized conditions for enzymatic reactions that are not possible in other areas of the cell. Although the mitochondria have a small genome, the vast majority of genes that function within this organelle are nuclear encoded (~1100). The RNA from these genes must be transported across the cytoplasm and translated on the mitochondrial surface for correct protein folding. This is an important process for maintaining mitochondrial activity and number. Despite the importance of this process to human health, the mechanisms that act to coordinate the correct transport and translation of nuclear encoded mitochondrial genes (NEMG) are poorly understood. Key unanswered questions include: how is the localization of these mrnas orchestrated? What mechanisms regulate the protein synthesis of these factors at the mitochondria? And how does the disruption of these processes alter mitochondrial number and function? The family of pumilio (PUM) RNA-binding proteins (RBPS) have important roles in regulating development, pluripotency, growth and neuronal function. Mutations within the human PUMILIO1 (PUM1) gene cause spinocerebellar ataxia type 47. These patients present with early onset neurodevelopmental disorders, ataxia and a raft of additional neurological symptoms. Despite the identification of causative mutations within PUM1, how these mutations contribute to these pathologies are poorly defined. To better understand PUM1 targets, we conducted eclip-RNA-SEQ profiling of PUM1 from human cells and mouse brains and unexpectedly found that roughly a quarter (26% in humans and 23% in mice) of the 1100 nemgs are direct PUM1 substrates. RNA-SEQ and proteomic profiling of PUM1-KO mouse brains identified widespread alterations in the levels of nemgs both at the RNA and protein levels. This results in changes in mitochondrial numbers, respiration rates and metabolic profiles. This highlights an unknown role for PUM1 in mitochondrial homeostasis. However, as PUM1 regulates both NEMG and non-NEMG mrnas, the CO-factors that cooperate with PUM1 to modulate NEMG mrna are unknown. Using computational and mass spectrometry profiling, we show that the lrpprc RBP binds to NEMG mrna via a novel RNA structural element and that this promotes NEMG RNA mitochondrial localization. Intriguingly, PUM1 mass spectrometry interactome experiments show that lrpprc and PUM1 are direct binders, providing a putative mechanism of regulation. Despite this strong preliminary data, the mechanisms of lrpprc-PUM1-NEMG RNA interactions, the substrates of lrpprc-PUM1 binding/regulation and the effect of PUM1 pathogenic mutations on this regulatory network remain unknown.
Quick answers
Who received award RNS152185UAJWR1?
RNS152185UAJWR1 was awarded to The Ohio State University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on November 17, 2026.
How much is award RNS152185UAJWR1 worth?
$627,318 has been obligated on RNS152185UAJWR1.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award